Speakers

Sort by
Newest
Trending
1-30 of 230
Filter
Richard Sams
Scientific Director at KCA Laboratories
bioavailability, calibration, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, certification, certified reference materials, chromatography, clinical trial, contamination, crystallization, delta-8-tetrahydrocannabinol, first pass effect, fume hood, good manufacturing practice, high-performance liquid chromatography, inductively coupled plasma mass spectrometry, institutional review board, iso/iec 17025, laboratory, laboratory glassware, lipophilicity, m&m's, mass spectrometry, measurement, natural product, nutraceutical, observational error, ph, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, pipette, ratio, reproducibility, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, thin-layer chromatography, truth, uncertainty, waters corporation
Tristan Searra
Owner at 11:11 CBD LTD
brand, cannabidiol, cannabinoid, cannabis, conor mcgregor, disinfectant, drug test, elon musk, endocannabinoid system, floyd mayweather jr., food, golf, hangover, hemp, medication, organic certification, organic food, plant, retail, smoking, tetrahydrocannabinol, truck driver, united kingdom, vegetable, water
Matthew Werner
Business Development Manager at Kaizen Global Partners
brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), certificate of analysis, concept, don julio, emulsion, end user, graphic design, hemp, hydrophobe, liquid, mind, non-disclosure agreement, petroleum, pricing, social media, social media marketing, supply chain, target market, tetrahydrocannabinol, washing machine, water
Priscilla Agoncillo
Co-Founder at Original Breeders League
anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis industry, democratic party (united states), dispensary, dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, food and drug administration, free market, gerrymandering, good manufacturing practice, hair loss, health care, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, mood stabilizer, neuroplasticity, neurotransmitter, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, selective serotonin reuptake inhibitor, sense, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression
Debra Smith-Torrence
CEO and Founder at Auspicious Wellness CBD Products and Distribution
agriculture, authorize.net, bill (law), cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, celebrity, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, drug test, facebook, food, food and drug administration, good manufacturing practice, health food, hemp, indiana general assembly, instagram, irrigation, karen tallian, knowledge, license, linkedin, medical cannabis, mind, nutraceutical, pharmaceutical industry, placebo-controlled study, qr code, reading (legislature), reason, research, science, target audience, terpene, tetrahydrocannabinol, the new york times, united states senate, veto, water, youtube
Sierra Liggett
Specialty Packaging Manager - Cannabis & E-Commerce at Budpack
cannabidiol, cannabis (drug), clinical trial, controlled substances act, dietary supplement, fda warning letter, federal trade commission, good manufacturing practice, ibuprofen, medical cannabis, medicare (united states), medication, new drug application, nonsteroidal anti-inflammatory drug, over-the-counter drug, packaging and labeling, paracetamol, personal protective equipment, pharmaceutical industry, supply chain, tetrahydrocannabinol, tylenol (brand), understanding
Colby Watkins
COO at WherezHemp
absorption (pharmacology), alternative medicine, amazon (company), anti-inflammatory, anti-predator adaptation, appetite, aromatherapy, audit, bank, behavior, blog, blood alcohol content, book, botany, brand, brand loyalty, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, chemical substance, coffee, coffee bean, coffeehouse, communication, communication protocol, community, competition, customer relationship management, dose (biochemistry), drink, due diligence, email, email spam, emerging market, entourage effect, essential oil, facebook, food, food and drug administration, globalization, gluten-free diet, good manufacturing practice, google, hemp, herbal distillate, hindsight bias, insurance, juice, lemon, ligand (biochemistry), limonene, linkedin, mango, margin of error, medication, nsf international, nutraceutical, opt-in email, organic certification, pain, peer-to-peer, price, reason, red bull, regulatory compliance, risk management, sales, sales process engineering, secondary metabolite, social media, software , solvent, spectrum, starbucks, target corporation, telecommuting, terpene, terpenoid, tetrahydrocannabinol, trade, walmart, water, water activity, youtube
Michael Flemmens
VP of Technical Business Development at SōRSE Technology
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, attention, blinded experiment, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis industry, chemical substance, clinicaltrials.gov, coffee, coffee bean, coffeehouse, coronavirus disease 2019, diesel fuel, distillation, dose (biochemistry), food, food and drug administration, hospital, ibuprofen, in vitro, innovation, laboratory, ligand (biochemistry), medication, molecule, nutraceutical, pain, pharmaceutical industry, pharmacokinetics, randomized controlled trial, red bull, solvent, starbucks, steam distillation, supercritical fluid, tetrahydrocannabinol, women's health
Austin Rhodus
Director Of Membership Services at Midwest Hemp Council
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, dose (biochemistry), food, ligand (biochemistry), medication, nutraceutical, pain, red bull, solvent, starbucks, tetrahydrocannabinol
Ryan Bellone
Commercial Director at KCA Labs
bioavailability, calibration, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, certification, certified reference materials, chromatography, clinical trial, contamination, crystallization, delta-8-tetrahydrocannabinol, first pass effect, fume hood, good manufacturing practice, high-performance liquid chromatography, inductively coupled plasma mass spectrometry, institutional review board, iso/iec 17025, laboratory, laboratory glassware, lipophilicity, m&m's, mass spectrometry, measurement, natural product, nutraceutical, observational error, ph, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, pipette, ratio, reproducibility, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, thin-layer chromatography, truth, uncertainty, waters corporation
Alan Robinson
Co-Founder at Herbal Aspect
bioavailability, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, first pass effect, high-performance liquid chromatography, institutional review board, lipophilicity, mass spectrometry, natural product, nutraceutical, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, waters corporation
Joe Linne
Owner at Hoosier Hempster
adverse effect, agriculture, authorize.net, bill (law), brand, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), celebrity, credit card, dietary supplement, driving under the influence, drug test, economic bubble, facebook, food, food and drug administration, health food, indiana general assembly, innovation, inventory, irrigation, karen tallian, kevin o'leary, knowledge, marketing plan, medical prescription, medication, mind, peripheral neuropathy, placebo-controlled study, reading (legislature), reason, regulatory compliance, research, risk, science, tetrahydrocannabinol, tetrahydrocannabinolic acid, the new york times, united states senate, veto, visa inc., water, zero tolerance
Justin Swanson
Principal at Bose Public Affairs Group and Of Counsel at Bose McKinney & Evans
adverse effect, brand, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), credit card, driving under the influence, drug test, economic bubble, food and drug administration, innovation, inventory, kevin o'leary, marketing plan, medical prescription, medication, peripheral neuropathy, regulatory compliance, risk, tetrahydrocannabinol, tetrahydrocannabinolic acid, visa inc., zero tolerance
Greg Kruger
Founding Partner/Chief Operating Officer at DREEM Nutrition
adverse effect, brand, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), credit card, driving under the influence, drug test, economic bubble, food and drug administration, innovation, inventory, kevin o'leary, marketing plan, medical prescription, medication, peripheral neuropathy, regulatory compliance, risk, tetrahydrocannabinol, tetrahydrocannabinolic acid, visa inc., zero tolerance
John Leja
Founder, Board Member at NuSierra Holdings
agriculture, brand, cannabidiol, cannabis, concept, consumer confidence, convertible bond, cosmetics, crop rotation, crowdfunding, cultivator, debenture, debt, dietary supplement, discounting, farmers' market, financial capital, food and drug administration, hamburger, health claim, hemp, integrated pest management, interest, interest rate, investment, investor, maize, medical cannabis, mergers and acquisitions, mind, option (finance), organic certification, organic farming, pesticide, prescription drug, retail, soul, stock, stock dilution, tetrahydrocannabinol, traceability, valuation (finance), weed
Travis Chrisman
CEO at Coastal Labs
attention, bank, blinded experiment, bodyguard, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinicaltrials.gov, coffee, coffee bean, coronavirus disease 2019, credit card, crime, diesel fuel, distillation, electronic cigarette, fence (criminal), financial crime, food and drug administration, hospital, hsbc, ibuprofen, in vitro, innovation, jpmorgan chase, laboratory, mastercard, medical cannabis, molecule, money laundering, paypal, pharmaceutical industry, pharmacokinetics, price, randomized controlled trial, steam distillation, supercritical fluid, suspicious activity report, tetrahydrocannabinol, underwriting, united states department of agriculture, united states postal service, visa inc., women's health
Rocco Iannapollo
Director Of Business Development at Cannabis Kitchen Supplies
brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), certificate of analysis, concept, don julio, emulsion, end user, graphic design, hemp, hydrophobe, liquid, mind, non-disclosure agreement, petroleum, pricing, social media, social media marketing, supply chain, target market, tetrahydrocannabinol, washing machine, water
Ian James
Founder and CEO at The Ideation Lab, LLC
aphria (company), brand, cannabidiol, cannabinoid, cannabis, coffee, cosmetics, distribution (marketing), flavor, food, food and drug administration, kool-aid, marketplace, mountain dew, nestea, novel food, pharmacy, pricing, recycling, retail, shelf life, soft drink, tea, tetrahydrocannabinol, toast (honor)
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Dean Johnson
President at Applied Botanics
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Evan Ogburn
Founder at PHARM CBD
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Rebecca Zirkle
Owner & Founder at Cultivate Hope Chemovar
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, food and drug administration, good manufacturing practice, hemp, instagram, license, linkedin, medical cannabis, nutraceutical, pharmaceutical industry, qr code, target audience, terpene, tetrahydrocannabinol, youtube
Ricky Chandler
Co-Founder at CBD WIILLY
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, food and drug administration, good manufacturing practice, hemp, instagram, license, linkedin, medical cannabis, nutraceutical, pharmaceutical industry, qr code, target audience, terpene, tetrahydrocannabinol, youtube
Ryan McFarland
CEO at WhereZHemp
aphria (company), brand, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, coffee, convertible bond, cosmetics, crowdfunding, debenture, debt, delta-8-tetrahydrocannabinol, dietary supplement, discounting, distribution (marketing), dose (biochemistry), drug enforcement administration, financial capital, flavor, food, food and drug administration, good manufacturing practice, health claim, hemp, instagram, interest, interest rate, investment, investor, kool-aid, license, linkedin, marketplace, medical cannabis, mergers and acquisitions, mountain dew, nestea, novel food, nutraceutical, option (finance), organic certification, pharmaceutical industry, pharmacy, prescription drug, pricing, qr code, recycling, retail, shelf life, soft drink, stock, stock dilution, target audience, tea, terpene, tetrahydrocannabinol, toast (honor), valuation (finance), youtube
Liz Geisleman
Vice President at Rocky Mountain Reagents
advertising, anti-inflammatory, brand, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, class action, damages, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug, drug enforcement administration, false advertising, federal trade commission, food, food and drug administration, good manufacturing practice, hemp, instagram, law, lawsuit, license, linkedin, medical cannabis, medication, new drug application, nutraceutical, pharmaceutical industry, pharmacy, product testing, qr code, regulatory compliance, social media, target audience, terpene, tetrahydrocannabinol, youtube
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Keith Johnson
Business Owner at The Carboxyl Group
cannabidiol, cannabis (drug), clinical trial, controlled substances act, dietary supplement, fda warning letter, federal trade commission, good manufacturing practice, ibuprofen, medical cannabis, medicare (united states), medication, new drug application, nonsteroidal anti-inflammatory drug, over-the-counter drug, packaging and labeling, paracetamol, personal protective equipment, pharmaceutical industry, supply chain, tetrahydrocannabinol, tylenol (brand), understanding
Bryant Jones
Plant Scientist, Herbalist at University Of Minnesota
1996 california proposition 215, adolescence, agriculture, agronomy, american chemical society, amino acid, aphid, attention, automation, bacteria, bicycle, biological pest control, biotechnology, blinded experiment, brand, candy, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis cultivation, cannabis indica, cannabis sativa, carbon dioxide in earth's atmosphere, carbon sequestration, charlotte's web (cannabis), chemist, chemistry, clay, clinicaltrials.gov, coffee, coffee bean, concept, consumer confidence, coronavirus disease 2019, crop rotation, cultivar, cultivator, curveball, decomposition, diesel fuel, dietary supplement, distillation, dna sequencing, dominance (genetics), drink, due diligence, ecology, ecosystem, education, endocannabinoid system, engineer, entourage effect, experience, farmer, farmers' market, fda warning letter, fertigation, fertilizer, food and drug administration, fungus, gardening, gene, generally recognized as safe, genetically modified crops, genetically modified food, genetically modified organism, genetics, genomics, germination, glyphosate, good manufacturing practice, grasshopper, greenhouse, gummy candy, hamburger, hash oil, health claim, hemp, herb, heterosis, hospital, hot chocolate, ibuprofen, impatiens necrotic spot virus, in vitro, infection, innovation, insect, integrated pest management, interdisciplinarity, ion, ion-exchange, irrigation, irrigation in viticulture, laboratory, lavandula, lawyer, learning, maize, market (economics), mediation, medical cannabis, medication, medicinal plants, microbiota, microorganism, mind, molecule, monopoly, mycorrhiza, natural environment, natural resource, natural selection, news, nitrate, nitrite, nitrogen, no-till farming, nonprofit organization, nutrient, nutrition, organic certification, organic farming, organic matter, over-the-counter drug, pansy, password, pathogen, pest control, pesticide, pharmaceutical industry, pharmacokinetics, pharmacovigilance, phenotype, phloem, photorespiration, photosynthesis, phytochemical, plant breeding, plant nursery, plant tissue culture, plant virus, question, race (human categorization), randomized controlled trial, recycling, research and development, research, and development, retail, reverse engineering, root, sales, sampling (statistics), scott gottlieb, sense, silt, slider (baseball), smoking, social media, social stigma, soil, soul, soybean, steam distillation, sucrose, supercritical fluid, supply chain, surface runoff, sustainability, technology, terpene, tetrahydrocannabinol, time, tomato, traceability, transpiration, tree, united states department of agriculture, united states farm bill, vegetative reproduction, videotelephony, virus, vitis, washington (state), water, weed, wheat, women's health, xylem
1 2 3 4 5 6 7 8